Skip to Content

CNN – Health

Discrimination of any kind can lead to much higher risk of mental and behavioral issues for young people, study finds

By Kristen Rogers, CNN Young adults who experience discrimination about their bodies, race, age or sex have a greater risk of dealing with mental health problems than those who do not, a new study has found. Encountering discrimination — especially racism — has long been associated with negative effects on overall well-being, such as higher

Continue Reading

Novavax to complete data submission to FDA by end of the year for authorization of its coronavirus vaccine

By Jacqueline Howard, CNN The biotechnology company Novavax plans to submit complete data to the US Food and Drug Administration soon for possible emergency use authorization of its coronavirus vaccine, CEO Stanley Erck told CNN in a phone interview Friday. “We’ll have a file in the US hopefully before the end of the year,” Erck

Continue Reading

Even if they get breakthrough infections, vaccinated people don’t get as sick with Covid-19, studies show

CNN By Maggie Fox, CNN Even if they get a breakthrough infection, vaccinated people don’t get as sick with Covid-19, two different teams of researchers reported Thursday. Both studies show the vaccines strongly protect against severe disease and death, even months after people were first vaccinated and as the more transmissible Delta variant renewed the

Continue Reading

Even if they get breakthrough infections, vaccinated people don’t get as sick with Covid-19, studies show

By Maggie Fox, CNN Even if they get a breakthrough infection, vaccinated people don’t get as sick with Covid-19, two different teams of researchers reported Thursday. Both studies show the vaccines strongly protect against severe disease and death, even months after people were first vaccinated and as the more transmissible Delta variant renewed the spread

Continue Reading

UK becomes first to authorize Merck and Ridgeback Biotherapeutics’ antiviral molnupiravir to treat mild-to-moderate Covid-19

By Jamie Gumbrecht, CNN The UK Medicines and Healthcare Products Regulatory Agency said Thursday it had authorized Merck and Ridgeback Biotherapeutics’ oral antiviral, molnupiravir, to treat mild-to-moderate Covid-19 in adults at risk for severe illness. It is the world’s first oral antiviral to be authorized anywhere for the treatment of Covid-19. The drug comes in

Continue Reading